|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 17 of 212 found articles
| Title: |
6MO Pembrolizumab plus ipilimumab or placebo in previously untreated metastatic NSCLC with PD-L1 tumor proportion score ≥50%: KEYNOTE-598 3-year follow-up |
| Author: |
Rodriguez Abreu, D. Reck, M. Şendur, N. Park, K. Lee, D.H. Cicin, I. Yumuk, P.F. Orlandi, F.J. Leal, T.A. Soparattanapaisarn, N. Langleben, A. Califano, R. Medgyasszay, B. Hsia, T-C. Otterson, G.A. Woods, T. Jensen, E. Samkari, A. Boyer, M. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 33 () nr. S2 pages S30-S31 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 17 of 212 found articles
| << previous | next >> |